Arterburn DE, Crane PK, Veenstra DI. The efficacy and safety of sibutramine for weight loss: a systematic review.
Arch Intern Med.
Facts and comparisons.
Drug Facts and Comparisons. 56th ed. St. Louis, MO: Facts and Comparisons; 2001.
Haddock CK, Poston WSW, Dill PL, Foreyt JP, Ericsson M. Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials.
Int J Obes Relat Meta Disord.
Li Z, Maglione M, Mojica W, Arterburn D, et al. Meta-analysis: Pharmacologic treatment of obesity.
Ann Intern Med.
Snow V, Barry P, Fitteman N, Qaseem A, et al. Pharmacologic and surgical management of obesity in primary care: a clinical practice guidelines from the American College of Physicians.
Ann Intern Med.
Weight loss medications for obesity in adults. EBSCO DynaMed website. Available at:
http://www.ebscohost.com/dynamed/. Updated July 18, 2012. Accessed August 28, 2012.
Wirth A, Krause J. Long-term weight loss with sibutramine: A randomized controlled trial.
9/17/2010 DynaMed's Systematic Literature Surveillance
DynaMed's Systematic Literature Surveillance: James WP, Caterson ID, Coutinho W, et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.
N Engl J Med.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.